Guimarães FS[Author] - Search Results

Year	Number of Results
1983	1
1987	2
1989	1
1990	2
1991	6
1993	9
1994	6
1995	3
1996	4
1997	7
1998	4
1999	4
2000	10
2001	9
2002	8
2003	7
2004	10
2005	11
2006	14
2007	12
2008	20
2009	18
2010	23
2011	27
2012	25
2013	33
2014	29
2015	28
2016	24
2017	23
2018	31
2019	30
2020	20
2021	7

1

Cannabidiol, neuroprotection and neuropsychiatric disorders.

Campos AC, Fogaça MV, Sonego AB, Guimarães FS. Campos AC, et al. Among authors: guimaraes fs. Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033. Epub 2016 Feb 1. Pharmacol Res. 2016. PMID: 26845349 Review.

2

Animal models of anxiety disorders and stress.

Campos AC, Fogaça MV, Aguiar DC, Guimarães FS. Campos AC, et al. Among authors: guimaraes fs. Braz J Psychiatry. 2013;35 Suppl 2:S101-11. doi: 10.1590/1516-4446-2013-1139. Braz J Psychiatry. 2013. PMID: 24271222 Free article. Review.

3

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.

Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Crippa JA, et al. Among authors: guimaraes fs. Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.

4

The Endocannabinoid System and Anxiety.

Lisboa SF, Gomes FV, Terzian AL, Aguiar DC, Moreira FA, Resstel LB, Guimarães FS. Lisboa SF, et al. Among authors: guimaraes fs. Vitam Horm. 2017;103:193-279. doi: 10.1016/bs.vh.2016.09.006. Epub 2016 Nov 2. Vitam Horm. 2017. PMID: 28061971 Review.

5

Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.

Lee JLC, Bertoglio LJ, Guimarães FS, Stevenson CW. Lee JLC, et al. Among authors: guimaraes fs. Br J Pharmacol. 2017 Oct;174(19):3242-3256. doi: 10.1111/bph.13724. Epub 2017 Mar 9. Br J Pharmacol. 2017. PMID: 28268256 Free PMC article. Review.

6

Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Crippa JAS, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Dos Santos RG. Crippa JAS, et al. Among authors: guimaraes fs. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):121-133. doi: 10.1007/s00406-019-00982-6. Epub 2019 Jan 31. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30706171 Review.

7

Biological bases for a possible effect of cannabidiol in Parkinson's disease.

Ferreira-Junior NC, Campos AC, Guimarães FS, Del-Bel E, Zimmermann PMDR, Brum Junior L, Hallak JE, Crippa JA, Zuardi AW. Ferreira-Junior NC, et al. Among authors: guimaraes fs. Braz J Psychiatry. 2020 Apr;42(2):218-224. doi: 10.1590/1516-4446-2019-0460. Epub 2019 Jul 15. Braz J Psychiatry. 2020. PMID: 31314869 Free PMC article.

8

Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Junior NCF, Dos-Santos-Pereira M, Guimarães FS, Del Bel E. Junior NCF, et al. Among authors: guimaraes fs. Neurotox Res. 2020 Jan;37(1):12-29. doi: 10.1007/s12640-019-00109-8. Epub 2019 Oct 22. Neurotox Res. 2020. PMID: 31637586 Review.

9

Pursed lip breathing improves exercise tolerance in COPD: a randomized crossover study.

Cabral LF, D'Elia Tda C, Marins Dde S, Zin WA, Guimarães FS. Cabral LF, et al. Among authors: guimaraes fs. Eur J Phys Rehabil Med. 2015 Feb;51(1):79-88. Epub 2014 Apr 2. Eur J Phys Rehabil Med. 2015. PMID: 24691248 Free article. Clinical Trial.

10

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.

Linares IM, Zuardi AW, Pereira LC, Queiroz RH, Mechoulam R, Guimarães FS, Crippa JA. Linares IM, et al. Among authors: guimaraes fs. Braz J Psychiatry. 2019 Jan-Feb;41(1):9-14. doi: 10.1590/1516-4446-2017-0015. Epub 2018 Oct 11. Braz J Psychiatry. 2019. PMID: 30328956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results